Evidence map›Paper›PMID 30026654›Full record

ArticleThe Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics2018

Avoiding Exploitation in Phase I Clinical Trials: More than (Un)Just Compensation.

Matt Lamkin, Carl Elliott

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Observational
  2. Volunteering for Infection: Participant Perspectives on a Hepatitis C Virus Controlled Human Infection Model.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Matt LamkinAssociate Professor at the University of Tulsa College of Law. He earned an A.B. degree in Sociology at Princeton University (Princeton, NJ), a J.D. at Northwestern University Law School (Chicago, IL), and an M.A. in Bioethics at the University of Minnesota (Minneapolis, MN), and served as a Fellow at Stanford Law School's Center for Law and the Biosciences.A professor in the Center for Bioethics and the Department of Pediatrics and an affiliate faculty member in the Department of Philosophy and the School of Journalism and Mass Communications at the University of Minnesota. He has a Ph.D. in philosophy from Glasgow University (Glasgow, Scotland), an M.D. from the Medical University of South Carolina (Charleston, SC), and a B.S. from Davidson College (Davidson, NC).
Carl ElliottAssociate Professor at the University of Tulsa College of Law. He earned an A.B. degree in Sociology at Princeton University (Princeton, NJ), a J.D. at Northwestern University Law School (Chicago, IL), and an M.A. in Bioethics at the University of Minnesota (Minneapolis, MN), and served as a Fellow at Stanford Law School's Center for Law and the Biosciences.A professor in the Center for Bioethics and the Department of Pediatrics and an affiliate faculty member in the Department of Philosophy and the School of Journalism and Mass Communications at the University of Minnesota. He has a Ph.D. in philosophy from Glasgow University (Glasgow, Scotland), an M.D. from the Medical University of South Carolina (Charleston, SC), and a B.S. from Davidson College (Davidson, NC).

Funding

LawSeq: Building a Sound Legal Foundation for Translating Genomics into Clinical ApplicationR01HG008605 · NHGRI · UNIVERSITY OF MINNESOTA · PI CLAYTON, ELLEN WRIGHT, LAWRENZ, FRANCES PATRICIA · 2016 to 2018
$2.2M
NHGRI NIH HHS R01 HG008605
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Research SubjectsClinical Trials, Phase I as TopicCommerceHuman ExperimentationHumansInformed ConsentRisk-TakingUnited States

Identifiers

PMID30026654
PMCPMC6047746

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.